PlumX Metrics
Embed PlumX Metrics

Levels of aminotransferases and lactate dehydrogenase in pregnant and preeclampsia fetuses

2019
  • 0
    Citations
  • 5
    Usage
  • 0
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Artifact Description

Hyperprolactinemia is endocrinology disorder of the hypothalamus-pituitary axis-gonade which manifests with high reproductive menstrual disorders and infertility.The purpose of the paper was to analyze the incidence of menstrual reproductive disorders (amenorrhea, oligomenorrhea, polimenorrhea) and galacthorrhea in to hyperprolactinemia. Material and methods The study included 125 patients. In group N (with hyperprolactinemia) included 35 women with menstrual disorders, galactorrhea and infertility. In group K (with normoprolactinemia) included 90 women with menstrual disorders, galactorrhea and infertility. Results The incidence of hyperprolactinemia N group was 28 % (hyperprolactinemia = 44.77 ng/ml) compared with group K with 72 % incidence (Hyperprolactinemia=8.83 ng/ml), which is statistical significance p <0.0001. Amanorrhea incidence N group was 25.71 % (prolactenemia=74.49 ng/ml) compared to group amanorrhea K values 5.56 % and frequency prolactenemia 14.22 ng/ml is with statistical significance p <0.0001. Oligomenorrhea incidence N group was 20 % compared with the incidence of oligomenorrhea K groups with 7.78 % incidence. Polimenorrhea N group is presented with 11.43 % incidence compared with the group K with 3.33 % incidence. Galactorrhea shown incidence 34.29 % (prolactinemia =64.49 ng/ml) N group compared to the values of K group with the incidence of 3.33 % and (prolactenemia =15.06 ng/ml) that is with statistical signifikanc p <0.0001. Statistical analyses are made through the paired t-test and unpaired t-test. Conclusion Menstrual disorders fertility (amenorrhea, oligomenorhea, polimenorrhea) and galactorrhea are measured with high incidence and statistical signifikance hyperprolactinemia compared with control group (normoprolactinemia).

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know